What is the recommended immediate and early secondary‑prevention management for a patient who has just experienced a transient ischemic attack?

TIA Management: Immediate and Early Secondary Prevention

Immediate Actions (0-24 Hours)

All patients presenting within 48 hours of a TIA with unilateral weakness (face, arm, or leg) or speech disturbance must be transferred immediately to an emergency department with CT/MRI capability for urgent brain and vascular imaging. 1

Emergency Department Evaluation

• Brain imaging (MRI with diffusion-weighted imaging preferred, CT acceptable) must be completed within 24 hours to detect silent infarction, which occurs in up to 31% of TIA patients and markedly raises recurrence risk 1, 2
• Vascular imaging via CTA from aortic arch to vertex should be performed immediately, ideally concurrent with brain CT, to identify symptomatic carotid stenosis ≥70% requiring urgent revascularization 1, 2
  • Alternative modalities when CTA unavailable: carotid duplex ultrasound or MRA, selected by immediate availability 1, 2
• 12-lead ECG must be obtained immediately to detect atrial fibrillation and other cardioembolic sources 1, 2
• Laboratory panel: complete blood count, electrolytes, coagulation studies (aPTT, INR), renal function (creatinine/eGFR), random glucose or HbA1c, troponin 1, 2

Admission Criteria (Mandatory Hospitalization)

Admit immediately if any of the following are present: 2, 3

• First TIA within prior 24-48 hours
• Crescendo TIAs (multiple, increasingly frequent episodes)
• Symptom duration >1 hour at presentation
• Symptomatic carotid stenosis >50%
• Known cardiac embolic source (atrial fibrillation, mechanical valve)
• Documented hypercoagulable state
• Acute cerebral infarction on imaging
• NIHSS score ≥1 (indicates active minor stroke, not resolved TIA) 3

Critical pitfall: Never discharge patients with crescendo TIAs under any circumstances. 2

---

Dual Antiplatelet Therapy Protocol (Days 1-21)

Eligibility Criteria

• Minor ischemic stroke (NIHSS ≤3) or high-risk TIA (ABCD² ≥4) 1
• Presenting within 24-72 hours of symptom onset 1
• Intracranial hemorrhage excluded on imaging 1
• No recent IV alteplase (or ≥24 hours after thrombolysis) 1

Dosing Regimen

• Loading dose (Day 1): Clopidogrel 300 mg + aspirin 160-325 mg, administered within 12-24 hours of symptom onset 1
• Maintenance (Days 2-21): Clopidogrel 75 mg daily + aspirin 81-100 mg daily for exactly 21 days 1
• Efficacy: Reduces recurrent stroke by 25-32% (HR 0.68-0.75), NNT 67-91, NNH for major bleeding ≈200 1

Critical limitation: DAPT must not be extended beyond 21-30 days unless a separate cardiac indication exists, because bleeding risk then outweighs benefit. 1

---

Blood Pressure Management

Acute Phase (First 24-72 Hours)

• Permit permissive hypertension unless BP >220/120 mmHg; rapid reduction can impair cerebral perfusion 1, 2

Sub-Acute & Long-Term (After 72 Hours)

• Initiate or restart antihypertensive therapy within a few days after the acute window 1, 2
• Target BP: <130/80 mmHg for all TIA patients, which lowers recurrent stroke risk by ≈30% 1
• Preferred regimen: ACE-inhibitor + thiazide diuretic as first-line combination; ARBs or thiazides as alternatives 1
• Timeline: Achieve target BP control within 3 months of therapy initiation 1

---

Lipid Management

• All TIA patients should receive high-intensity statin therapy regardless of baseline cholesterol: atorvastatin 80 mg daily or rosuvastatin 20-40 mg daily 1, 4
• Goal: LDL-C <70 mg/dL and ≥50% reduction from baseline 1
• Timing: Initiate statin during hospitalization or immediately after discharge; re-check fasting lipids at 4-12 weeks, then every 3-12 months 1

Evidence from SPARCL trial: In 4,731 TIA/stroke patients, atorvastatin 80 mg reduced ischemic stroke (9.2% vs. 11.6% placebo) over 4.9 years. 4

---

Carotid Revascularization

• 70-99% ipsilateral extracranial carotid stenosis: Refer for endarterectomy within 6 months (ideally within 2 weeks) to maximize benefit 1, 2
• 50-69% stenosis: May be considered for surgery based on individualized risk assessment 1
• Critical window: Benefit of carotid endarterectomy diminishes rapidly after 2 weeks from symptom onset 2, 3
• Intensive medical therapy (antiplatelet, BP control, statin) should be continued irrespective of surgical decision 1

---

Anticoagulation for Cardioembolic TIA

• If atrial fibrillation is identified, replace antiplatelet therapy with oral anticoagulation 1, 2
• Preferred agents: Direct oral anticoagulants (DOACs)—apixaban, dabigatran, edoxaban, or rivaroxaban—over warfarin 1
• Warfarin (target INR 2.0-3.0) remains indicated for moderate-to-severe mitral stenosis or mechanical heart valves 1

Important: Oral anticoagulation is not recommended for non-cardioembolic TIA because current evidence shows no additional benefit over antiplatelet therapy and higher risk of intracerebral hemorrhage. 1

---

Transition to Single Antiplatelet Therapy (After Day 21)

After 21 days of DAPT, continue one of the following indefinitely: 1, 5

• Aspirin 75-100 mg daily (most cost-effective)
• Clopidogrel 75 mg daily (preferred if aspirin intolerance)
• Aspirin 25 mg + extended-release dipyridamole 200 mg twice daily (alternative regimen)

All three regimens are considered equally effective for long-term secondary prevention. 1, 5

---

Additional Risk Factor Management

• Diabetes: Aim for HbA1c <7% while maintaining aggressive BP control 1
• Lifestyle modifications: 1
  • Smoking cessation (mandatory)
  • Regular physical activity (≥150 minutes/week moderate-intensity aerobic activity)
  • Weight control
  • Mediterranean-type diet
  • Sodium restriction <2 g/day
  • Moderation of alcohol
  • Avoid stimulants and intravenous opioids

---

Risk Context: Why Urgency Matters

• Without urgent treatment: 7-day stroke risk is 10-11%, rising to ≈36% in patients with multiple vascular risk factors 1, 2, 6
• With rapid specialized stroke care: 7-day stroke risk drops to 2.1%, representing an ≈80% relative risk reduction 1, 2
• Highest risk period: First 48 hours after TIA, with half of all strokes occurring in the first 2 days 1, 2

---

Implementation Timeline

Timeframe	Critical Actions
0-24 h	Brain/vascular imaging (CTA arch-to-vertex), ECG, DAPT loading (if eligible), admit to stroke unit, start high-intensity statin [1,2]
24-72 h	Continue DAPT, allow permissive hypertension, complete laboratory work-up [1,2]
Days 3-7	Initiate/restart antihypertensive therapy; schedule carotid endarterectomy if ≥70% stenosis [1,2]
Day 21	Switch from DAPT to single antiplatelet therapy [1]
3 months	Achieve BP <130/80 mmHg and LDL-C <70 mg/dL [1]
Lifelong	Continue single antiplatelet, statin, BP control, and risk-factor modification [1]

---

Common Pitfalls to Avoid

• Never discharge patients with crescendo TIAs 2
• Do not rely solely on ABCD² scores for disposition decisions—they supplement but do not replace comprehensive evaluation 2
• Do not delay carotid imaging in anterior circulation TIAs, as urgent revascularization may be needed 2
• Never discharge without confirming outpatient follow-up arrangements 2
• Educate all patients to return immediately if neurological symptoms recur, as this may indicate an evolving stroke amenable to thrombolytic therapy 2